PDCD1 and neoplasm: Furthermore, in the realm of γδ T cell research, it has been observed that the utilization of PD-1 inhibitors can augment their cytotoxic activity against tumor cells (116, 117), and this synergistic effect will provide more options for the treatment of tumors by γδ T cells.